Name | 3-bromo-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine |
---|---|
Synonyms |
3-Bromo-5,6,7,8-tetrahydro[1,2,4]triazolo[4,3-a]pyrazine
1,2,4-Triazolo[4,3-a]pyrazine, 3-bromo-5,6,7,8-tetrahydro- 3-Bromo-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine hydrochloride |
Density | 2.2±0.1 g/cm3 |
---|---|
Boiling Point | 384.8±52.0 °C at 760 mmHg |
Molecular Formula | C5H7BrN4 |
Molecular Weight | 203.040 |
Flash Point | 186.5±30.7 °C |
Exact Mass | 201.985397 |
PSA | 42.74000 |
LogP | -0.05 |
Vapour Pressure | 0.0±0.9 mmHg at 25°C |
Index of Refraction | 1.835 |
HS Code | 2933990090 |
---|
~85% 903130-08-5 |
Literature: CANCER RESEARCH TECHNOLOGY LIMITED; HOELDER, Swen; BLAGG, Julian; CHEUNG, Jack; ATRASH, Butrus; SHELDRAKE, Peter Patent: WO2014/37751 A1, 2014 ; Location in patent: Paragraph 00459-00461 ; |
Precursor 1 | |
---|---|
DownStream 0 |
HS Code | 2933990090 |
---|---|
Summary | 2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |